RESEARCH PAPER
Factors associated with anxiety in children and adolescents with HIV infection
1
Department of Child Health, Faculty of Medicine, Udayana University/Sanglah General Hospital, Denpasar, Bali, Indonesia
2
Praya General Hospital, Central Lombok, West Nusa Tenggara, Indonesia
Submission date: 2021-06-17
Final revision date: 2021-10-26
Acceptance date: 2021-10-26
Publication date: 2022-04-26
HIV & AIDS Review 2022;21(2):137-143
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Children and adolescents with human immunodeficiency virus (HIV) infection, usually have several complex problems, both biological and psychiatric. This study aimed to investigate factors associated with anxiety in children and adolescents with HIV.
Material and methods:
This cross-sectional study was conducted at allergy-immunology outpatient clinic in Sanglah Hospital, Denpasar, Indonesia. A total of 60 children and adolescents aged 7-18 years were assessed using Spence children’s anxiety scale to detect anxiety. Associated factors included age, gender, orphan status, primary caregiver, clinical stage, CD4+ count, hospitalization, and disclosure status. Statistical analysis was performed using χ2 test, followed by multivariate analysis with binary logistic regression. P-value less than 0.05 was considered significant.
Results:
Elevated anxiety symptoms were found in 22 subjects (36.7%) in the form of separation anxiety symptoms (72.7%), obsessive-compulsive disorder (50.0%), physical injury fear (45.5%), panic- agoraphobia (36.3%), social phobia (27.2%), and generalized anxiety disorder (22.7%). In multivariate analysis, older age (PR: 6.91; 95% CI: 1.55-30.89%) and orphan status (PR: 9.56; 95% CI: 1.12-81.89%) were independently associated with elevated anxiety symptoms.
Conclusions:
Elevated anxiety symptoms were prevalent among HIV-infected children and adolescents, primarily in the form of separation anxiety. Older age and orphan status were independently associated with elevated anxiety symptoms.
Children and adolescents with human immunodeficiency virus (HIV) infection, usually have several complex problems, both biological and psychiatric. This study aimed to investigate factors associated with anxiety in children and adolescents with HIV.
Material and methods:
This cross-sectional study was conducted at allergy-immunology outpatient clinic in Sanglah Hospital, Denpasar, Indonesia. A total of 60 children and adolescents aged 7-18 years were assessed using Spence children’s anxiety scale to detect anxiety. Associated factors included age, gender, orphan status, primary caregiver, clinical stage, CD4+ count, hospitalization, and disclosure status. Statistical analysis was performed using χ2 test, followed by multivariate analysis with binary logistic regression. P-value less than 0.05 was considered significant.
Results:
Elevated anxiety symptoms were found in 22 subjects (36.7%) in the form of separation anxiety symptoms (72.7%), obsessive-compulsive disorder (50.0%), physical injury fear (45.5%), panic- agoraphobia (36.3%), social phobia (27.2%), and generalized anxiety disorder (22.7%). In multivariate analysis, older age (PR: 6.91; 95% CI: 1.55-30.89%) and orphan status (PR: 9.56; 95% CI: 1.12-81.89%) were independently associated with elevated anxiety symptoms.
Conclusions:
Elevated anxiety symptoms were prevalent among HIV-infected children and adolescents, primarily in the form of separation anxiety. Older age and orphan status were independently associated with elevated anxiety symptoms.
REFERENCES (23)
1.
UNAIDS. Fact sheet world AIDS Day 2020. Available from: https://www.unaids.org/sites/d... (Accessed: 20.08.2020).
2.
Hazra R, Siberry GK, Mofenson LM. Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection. Annu Rev Med 2010; 61: 169-185.
3.
Elkington KS, Robbins RN, Bauermeister JA, Abrams EJ, McKay M, Mellins CA. Mental health in youth infected with and affected by HIV: the role of caregiver HIV. J Pediatr Psychol 2011; 36: 360-373.
4.
Mellins CA, Brackis-Cott E, Leu CS, et al. Rates and types of psychiatric disorders in perinatally human immunodeficiency virus-infected youth and seroreverters. J Child Psychol Psychiatry 2009; 50: 1131-1138.
5.
Scharko AM. DSM psychiatric disorders in the context of pediatric HIV/AIDS. AIDS Care 2006; 18: 441-445.
6.
Betancourt T, Scorza P, Kanyanganzi F, et al. HIV and child mental health: a case-control study in Rwanda. Pediatrics 2014; 134: e464-472.
7.
Gadow KD, Chernoff M, Williams PL, et al. Co-occuring psychiatric symptoms in children perinatally infected with HIV and peer comparison sample. J Dev Behav Pediatr 2010; 31: 116-128.
8.
Musisi S, Kinyanda E. Emotional and behavioural disorders in HIV seropositive adolescents in urban Uganda. East Afr Med J 2009; 86: 16-24.
9.
Woollett N, Cluver L, Bandeira M, Brahmbhatt H. Identifying risks for mental health problems in HIV positive adolescents accessing HIV treatment in Johannesburg. J Child Adolesc Ment Health 2017; 29: 11-26.
10.
Sadock BJ, Virginia A. Kaplan & Sadock’s Synopsis of Psychiatry. 8th ed. Philadelphia: Williams and Wilkins; 2008.
11.
Olofsdotter S, Sonnby K, Vadlin S, Furmark T, Nilsson KW. Assessing adolescent anxiety in general psychiatric care: diagnostic accuracy of the Swedish self-report and parent versions of the Spence Children’s Anxiety Scale. Assessment 2016; 23: 744-757.
12.
Spence SH, Barrett PM, Turner CM. Psychometric properties of the Spence Children’s Anxiety Scale with young adolescents. J Anxiety Disord 2003; 17: 605-625.
13.
Bankole KO, Bakare MO, Edet BE, et al. Psychological complications associated with HIV/AIDS infection among children in South-South Nigeria, sub-Saharan Africa. Cogent Medicine 2017; 4: 1372869.
14.
World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ. Tech. Rep. Ser. 854, vol. 854. Geneva: WHO; 1995.
15.
Kamau JW, Kuria W, Mathai M, Atwoli L, Kangethe R. Psychiatric morbidity among HIV-infected children and adolescents in a resource-poor Kenyan urban community. AIDS Care 2012; 24: 836-842.
16.
World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2nd ed. Geneva: World Health Organization; 2016. ANNEX 10, WHO clinical staging of HIV disease in adults, adolescents and children. Available at: https://www.ncbi.nlm.nih.gov/b....
17.
Bulali RE, Kibusi SM, Mpondo BCT. Factors associated with HIV status disclosure and its effect on treatment adherence and quality of life among children 6-17 years on antiretroviral therapy in Southern Highlands Zone, Tanzania: unmatched case control study. Int J Pediatr 2018; 2018: 8058291.
18.
Vreeman RC, Nyandiko WM, Ayaya SO, Walumbe EG, Marrero DG, Inui TS. The perceived impact of disclosure of pediatric HIV status on pediatric antiretroviral therapy adherence, child well-being, and social relationships in a resource-limited setting. AIDS Patient Care STDS 2010; 24: 639-649.
19.
Kinyanda E, Salisbury TT, Levin J, et al. Rates, types and co-occurrence of emotional and behavioural disorders among perinatally HIV-infected youth in Uganda: the CHAKA study. Soc Psychiatry Psychiatr Epidemiol 2019; 54: 415-425.
20.
Prout PH, Brown DT. Counseling and psychotherapy with children and adolescent: theory and practice for school and clinical settings. New Jersey: John Wiley and Sons; 2007.
21.
Atwine B, Cantor-Graae E, Bajunirwe F. Psychological distress among AIDS orphans in rural Uganda. Soc Sci Med 2005; 61: 555-564.
22.
Cluver LD, Orkin M, Gardner F, Boyes ME. Persisting mental health problems among AIDS-orphaned children in South Africa. J Child Psychol Psychiatry 2012; 53: 363-370.
23.
Mokgatle MM, Madiba S. The burden of disease on HIV-infected orphaned and non-orphaned children accessing primary health facilities in a rural district with poor resources in South Africa: a cross-sectional survey of primary caregivers of HIV-infected children aged 5-18 years. Infect Dis Poverty 2015; 4: 18.
Share
RELATED ARTICLE
| eISSN: | 1732-2707 |
| ISSN: | 1730-1270 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
